N < sup > 6 < /sup > -methyladenosine-modified circ_104797 sustains cisplatin resistance in bladder cancer through  acting as RNA sponges

CONCLUSIONS: Our findings unveil a previously uncharted mechanism underpinning cisplatin resistance and advocate the potential therapeutic targeting of circ_104797 in cisplatin-administered patients with BCa, offering a promising avenue for advanced BCa management.PMID:38395751 | PMC:PMC10893648 | DOI:10.1186/s11658-024-00543-3
Source: Cellular and Molecular Biology Letters - Category: Biochemistry Authors: Source Type: research